project id: TCGA-CESC; case submitter id: TCGA-EK-A2H1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 20; days to birth: -7649; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1987; age at diagnosis: 7649; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 799.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1319; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: 14fa244b-e920-46bd-8df0-849846c88344; sample submitter id: TCGA-EK-A2H1-01A; portion id: e1a1ba1d-e7e3-465e-8e3c-314d2720dac2; portion submitter id: TCGA-EK-A2H1-01A-11; slide id: b0ea350d-b3ca-482f-ac0f-32dcb8ff8db5; slide submitter id: TCGA-EK-A2H1-01A-01-TSA; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 2.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 70.0; section location: TOP;